Long-term results of a standardized enhanced recovery protocol in unilateral, secondary autologous breast reconstructions using an abdominal free flap.
Abstract
[BACKGROUND] In 2015, we published one of the first reports using an enhanced recovery protocol (ERP) in microsurgery, and in 2016, our final ERP setup in autologous breast reconstruction (ABR) using free abdominal flaps. We showed that by adhering to a few simple, easy to measure, functional discharge criteria, it was possible to safely discharge the patients by the third postoperative day (POD). However, one of the challenges of interpreting studies using ERP in ABR is the often heterogenous patient populations and the need to clearly distinguish between primary and secondary and unilateral and bilateral reconstructions.
[MATERIALS AND METHODS] In the 5-year period from 2016-2020, the same surgical team, performed 147 unilateral, delayed breast reconstructions (135 DIEP, 9 MS-TRAM-2, and 3 SIEA flaps) according to our previous analgesic protocol and surgical strategy. Data were collected prospectively.
[RESULTS] Three flaps were lost (2%) and 82% of the patients(n=128) were discharged to home by POD 2 (n=8%) or 3 (74%). The remaining 18% (n=26) were discharged by POD 4 (12.5%) or 5 (5.5%). Ten patients (7%) were reoperated, and 17 patients (12%) had minor complications within POD 30 (infection, seroma, etc.) that did not necessitate hospital admission.
[CONCLUSION] Using our ERP, unproblematic discharge directly to home is possible on POD 3 in more than 80% of patients after ABR. ERP is no longer a research tool but considered standard of care in microsurgical breast reconstruction.
[MATERIALS AND METHODS] In the 5-year period from 2016-2020, the same surgical team, performed 147 unilateral, delayed breast reconstructions (135 DIEP, 9 MS-TRAM-2, and 3 SIEA flaps) according to our previous analgesic protocol and surgical strategy. Data were collected prospectively.
[RESULTS] Three flaps were lost (2%) and 82% of the patients(n=128) were discharged to home by POD 2 (n=8%) or 3 (74%). The remaining 18% (n=26) were discharged by POD 4 (12.5%) or 5 (5.5%). Ten patients (7%) were reoperated, and 17 patients (12%) had minor complications within POD 30 (infection, seroma, etc.) that did not necessitate hospital admission.
[CONCLUSION] Using our ERP, unproblematic discharge directly to home is possible on POD 3 in more than 80% of patients after ABR. ERP is no longer a research tool but considered standard of care in microsurgical breast reconstruction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 4 | |
| 시술 | free flap
|
피판재건술 | dict | 1 | |
| 시술 | microsurgery
|
미세수술 | dict | 1 | |
| 해부 | bilateral
|
scispacy | 1 | ||
| 해부 | flaps
|
scispacy | 1 | ||
| 해부 | ERP
→ enhanced recovery protocol
|
scispacy | 1 | ||
| 해부 | abdominal
|
scispacy | 1 | ||
| 합병증 | flap
|
scispacy | 1 | ||
| 합병증 | abdominal flaps
|
scispacy | 1 | ||
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | infection
|
감염 | dict | 1 | |
| 약물 | [BACKGROUND] In
|
scispacy | 1 | ||
| 질환 | ERP
→ enhanced recovery protocol
|
scispacy | 1 | ||
| 질환 | POD
→ postoperative day
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | POD 2
|
scispacy | 1 | ||
| 기타 | POD 4
|
scispacy | 1 | ||
| 기타 | POD 30
|
scispacy | 1 |
MeSH Terms
Abdomen; Breast Neoplasms; Female; Free Tissue Flaps; Humans; Mammaplasty; Postoperative Complications; Retrospective Studies
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.